The epidemiology of psoriasis

References

• Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J. Am. Acad. Dermatol. 41(3 Pt 1), 401–407 (1999).
   PubMed Web of Science ®Google Scholar
• Javitz HS, Ward MM, Farber E, Nail L, Vallow SG. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J. Am. Acad. Dermatol. 46(6), 850–860 (2002).
   PubMed Web of Science ®Google Scholar
• Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med. 1(5), 442–447 (1995).
   PubMed Web of Science ®Google Scholar
• Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J. Am. Acad. Dermatol. 46(1), 1–23 (2002).
   PubMed Web of Science ®Google Scholar
• Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann. Rheum. Dis. 64 (Suppl. 2), 18–23 (2005).
   Google Scholar
• Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin. Exp. Dermatol. 26(4), 314–320 (2001).
   PubMed Web of Science ®Google Scholar
• Naldi L. Epidemiology of psoriasis. Curr. Drug Targets Inflamm. Allergy 3(2), 121–128 (2004).
   PubMedGoogle Scholar
• Naldi L. Inflammatory skin diseases IV: psoriasis. In: The Challenge of Dermato-epidemiology. Williams HC, Strachan DP (Eds). CRC Press LLC, FL, USA, 175–190 (1997).
   Google Scholar
• MacMahon B, Pugh TF. Epidemiology: Principles and Methods. Little, Brown and company, Boston, USA (1970).
   Google Scholar
• Hennekens CH, Buring JE. Epidemiology in Medicine. Lippincott Williams & Wilkins PA, USA (1987).
   Google Scholar
• Bell LM, Sedlack R, Beard CM et al. Incidence of psoriasis in Rochester, Minn, 1980–1983. Arch. Dermatol. 127(8), 1184–1187 (1991).
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Weinstein R, Porter SB et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch. Dermatol. 141(12), 1537–1541 (2005).
   PubMed Web of Science ®Google Scholar
• Yip SY. The prevalence of psoriasis in the Mongoloid race. J. Am. Acad. Dermatol. 10(6), 965–968 (1984).
   PubMed Web of Science ®Google Scholar
• Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 172(6), 298–304 (1986).
   PubMedGoogle Scholar
• Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol. Clin. 14(3), 485–496 (1996).
   PubMed Web of Science ®Google Scholar
• Hellgren L. Psoriasis. A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm. Venereol. 44(3), 191–207 (1964).
   PubMed Web of Science ®Google Scholar
• Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J. Investig. Dermatol. Symp. Proc. 9(2), 136–139 (2004).
   PubMed Web of Science ®Google Scholar
• Johnson MT, Roberts J. Skin conditions and related need for medical care among persons 1–74 years. United States, 1971–1974. Vital Health Stat. 11(212), 1–72 (1978).
   Google Scholar
• Kavli G, Forde OH, Arnesen E, Stenvold SE. Psoriasis: familial predisposition and environmental factors. Br. Med. J. 291(6501), 999–1000 (1985).
   PubMed Web of Science ®Google Scholar
• Ferrandiz C, Bordas X, Garcia-Patos V et al. Prevalence of psoriasis in Spain (Epiderma Project: Phase I). J. Eur. Acad. Dermatol. Venereol. 15(1), 20–23 (2001).
   PubMed Web of Science ®Google Scholar
• Lomholt G. Psoriasis: prevalence, spontaneous course and genetics. A census study on the prevalence of skin diseases in the Faroe Islands. Dan. Med. Bull. 11, 1–7 (1964).
   PubMedGoogle Scholar
• Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm. Venereol. Suppl. (Stockh.) 142, 9–12 (1989).
   PubMedGoogle Scholar
• Barisic-Drusko V, Paljan D, Kansky A, Vujasinovic S. Prevalence of psoriasis in Croatia. Acta Derm. Venereol. Suppl. (Stockh.) 146, 178–179 (1989).
   PubMedGoogle Scholar
• Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease. Br. J. Dermatol. 135(4), 533–537 (1996).
   PubMed Web of Science ®Google Scholar
• Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm. Venereol. 61(4), 344–346 (1981).
   PubMed Web of Science ®Google Scholar
• Naldi L, Colombo P, Placchesi R, Chatenoud L, La Vecchia C. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnosis of selected skin diseases in a representative sample of the Italian population. Dermatology 208(1), 38–42 (2004).
   PubMed Web of Science ®Google Scholar
• Falk ES, Vandbakk O. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm. Venereol. Suppl. (Stockh.) 182, 6–9 (1993).
   PubMedGoogle Scholar
• Gelfand JM, Stern RS, Nijsten T et al. The prevalence of psoriasis in African Americans: results from a population-based study. J. Am. Acad. Dermatol. 52(1), 23–26 (2005).
   PubMed Web of Science ®Google Scholar
• Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br. J. Prev. Soc. Med. 30(2), 107–114 (1976).
   PubMedGoogle Scholar
• Kavli G, Stenvold SE, Vandbakk O. Low prevalence of psoriasis in Norwegian lapps. Acta Derm. Venereol. 65(3), 262–263 (1985).
   PubMed Web of Science ®Google Scholar
• Quirk CJ. Skin disease in the Busselton population survey. Med. J. Aust. 1(12), 569–570 (1979).
   PubMed Web of Science ®Google Scholar
• Duffy DL, Spelman LS, Martin NG. Psoriasis in Australian twins. J. Am. Acad. Dermatol. 29(3), 428–434 (1993).
   PubMed Web of Science ®Google Scholar
• Braathen LR, Botten G, Bjerkedal T. Prevalence of psoriasis in Norway. Acta Derm. Venereol. Suppl. 142, 5–8 (1989).
   PubMedGoogle Scholar
• Farber EM, Nall L. Epidemiology: natural history and genetics. In: Psoriasis (3rd Edition). Roenigk HH, Maibach HI (Eds). Marcel Dekker, Inc., NY, USA, 107–158 (1998).
   Google Scholar
• Naldi L. Inflammatory skin diseases IV: psoriasis. In: The Challenge of Dermato-epidemiology. Strachan DP (Ed.). CRC Press, FL, USA, 175–187 (1997).
   Google Scholar
• Burch PR, Rowell NR. Mode of inheritance in psoriasis. Arch. Dermatol. 117(5), 251–252 (1981).
   PubMedGoogle Scholar
• Smith AE, Kassab JY, Rowland Payne CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 186(3), 181–186 (1993).
   PubMed Web of Science ®Google Scholar
• Ferrandiz C, Pujol RM, Garcia-Patos V, Bordas X, Smandia JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J. Am. Acad. Dermatol. 46(6), 867–873 (2002).
   PubMed Web of Science ®Google Scholar
• Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 13(3), 450–456 (1985).
   PubMed Web of Science ®Google Scholar
• Farber EM. Epidemiology: natural history and genetics. In: Psoriasis (2nd Edition). Roenigk HH, Maibach HI (Eds). Marcel Dekker, Inc., NY, USA, 209–258 (1991).
   Google Scholar
• Krueger GG, Eyre RW. Trigger factors in psoriasis. In: Dermatologic Clinics. Weinstein GD, Voorhees JJ (Eds). WB Saunders Co., PA, USA, 373–381 (1984).
   Google Scholar
• Krueger GG, Duvic M. Epidemiology of psoriasis: clinical issues. J. Invest. Dermatol. 102(6), S14–S18 (1994).
   PubMed Web of Science ®Google Scholar
• Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 148(1), 1–18 (1974).
   PubMedGoogle Scholar
• Gelfand JM, Feldman SR, Stern RS et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J. Am. Acad. Dermatol. 51(5), 704–708 (2004).
   PubMed Web of Science ®Google Scholar
• Spuls PI, Witkamp L, Bossuyt PM, Bos JD. The course of chronic plaque-type psoriasis in placebo groups of randomized controlled studies. Arch. Dermatol. 140(3), 338–344 (2004).
   PubMedGoogle Scholar
• Lomholt G. Environment and genetics in psoriasis. Ann. Clin. Res. 8(5), 290–297 (1976).
   PubMedGoogle Scholar
• Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J. Rheumatol. 13(3), 586–592 (1986).
   PubMed Web of Science ®Google Scholar
• Brandrup F, Holm N, Grunnet N, Henningsen K, Hansen HE. Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm. Venereol. 62(3), 229–236 (1982).
   PubMed Web of Science ®Google Scholar
• Farber EM, Nall ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch. Dermatol. 109(2), 207–211 (1974).
   PubMed Web of Science ®Google Scholar
• Watson W, Cann HM, Farber EM, Nall ML. The genetics of psoriasis. Arch. Dermatol. 105(2), 197–207 (1972).
   PubMedGoogle Scholar
• Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol. Clin. 22(4), 339–347 (2004).
   PubMed Web of Science ®Google Scholar
• Trembath RC, Clough RL, Rosbotham JL et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum. Mol. Genet. 6(5), 813–820 (1997).
   PubMed Web of Science ®Google Scholar
• Veal CD, Clough RL, Barber RC et al. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J. Med. Genet. 38(1), 7–13 (2001).
   PubMed Web of Science ®Google Scholar
• Capon F, Novelli G, Semprini S et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J. Invest. Dermatol. 112(1), 32–35 (1999).
   PubMedGoogle Scholar
• Capon F, Munro M, Barker J, Trembath R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J. Invest. Dermatol. 118(5), 745–751 (2002).
   PubMed Web of Science ®Google Scholar
• Balendran N, Clough RL, Arguello JR et al. Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J. Invest. Dermatol. 113(3), 322–328 (1999).
   PubMedGoogle Scholar
• Nair RP, Stuart P, Henseler T et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am. J. Hum. Genet. 66(6), 1833–1844 (2000).
   PubMed Web of Science ®Google Scholar
• Oka A, Tamiya G, Tomizawa M et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum. Mol. Genet. 8(12), 2165–2170 (1999).
   PubMed Web of Science ®Google Scholar
• Tamiya G, Shiina T, Oka A et al. New polymorphic microsatellite markers in the human MHC class I region. Tissue Antigens 54(3), 221–228 (1999).
   PubMedGoogle Scholar
• Mallon E, Newson R, Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a meta-analysis of published serologic studies. J. Invest. Dermatol. 113(4), 693–695 (1999).
   PubMed Web of Science ®Google Scholar
• Asumalahti K, Ameen M, Suomela S et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J. Invest. Dermatol. 120(4), 627–632 (2003).
   PubMed Web of Science ®Google Scholar
• Enerback C, Martinsson T, Inerot A et al. Significantly earlier age at onset for the HLA-Cw6-positive than for the Cw6-negative psoriatic sibling. J. Invest. Dermatol. 109(5), 695–696 (1997).
   PubMedGoogle Scholar
• Samuelsson L, Enlund F, Torinsson A et al. A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach. Hum. Genet. 105(6), 523–529 (1999).
   PubMedGoogle Scholar
• Tomfohrde J, Silverman A, Barnes R et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264(5162), 1141–1145 (1994).
   PubMed Web of Science ®Google Scholar
• Nair RP, Henseler T, Jenisch S et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. 6(8), 1349–1356 (1997).
   PubMed Web of Science ®Google Scholar
• Zheng J, Jin S, Shi R. Confirmation of PSORS psoriasis susceptibility loci in a Chinese population. Arch. Dermatol. Res. 295(1), 14–18 (2003).
   Google Scholar
• Schon MP, Boehncke WH. Psoriasis. Engl. J. Med. 352(18), 1899–1912 (2005).
   PubMed Web of Science ®Google Scholar
• Bowcock AM. The genetics of psoriasis and autoimmunity. Ann. Rev. Genomics Hum. Genet. 6, 93–122 (2005).
   PubMed Web of Science ®Google Scholar
• Leung DY, Walsh P, Giorno R, Norris DA. A potential role for superantigens in the pathogenesis of psoriasis. J. Invest. Dermatol. 100(3), 225–228 (1993).
   PubMed Web of Science ®Google Scholar
• Tagami H. Triggering factors. Clin. Dermatol. 15(5), 677–685 (1997).
   PubMed Web of Science ®Google Scholar
• Rosenberg EW, Noah PW, Zanolli MD et al. Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. J. Am. Acad. Dermatol. 14(5 Pt 1), 761–764 (1986).
   PubMed Web of Science ®Google Scholar
• Whyte HJ, Baughman RD. Acute guttate psoriasis and streptococcal infection. Arch. Dermatol. 89, 350–356 (1964).
   PubMed Web of Science ®Google Scholar
• Naldi L, Peli L, Parazzini F, Carrel CF. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J. Am. Acad. Dermatol. 44(3), 433–438 (2001).
   PubMed Web of Science ®Google Scholar
• Johnson TM, Duvic M, Rapini RP, Rios A. AIDS exacerbates psoriasis. N. Engl. J. Med. 313(22), 14–15 (1985).
   Google Scholar
• Duvic M. Papulosquamous disorders associated with human immunodeficiency virus infection. Dermatol. Clin. 9(3), 523–530 (1991).
   PubMedGoogle Scholar
• Ichihashi N, Seishima M, Takahashi T, Muto Y, Kitajima Y. A case of AIDS manifesting pruritic papular eruptions and psoriasiform lesions: an immunohistochemical study of the lesional dermal infiltrates. J. Dermatol. 22(6), 428–433 (1995).
   PubMedGoogle Scholar
• Laurence J, Hodtsev AS, Posnett DN. Superantigen implicated in dependence of HIV-1 replication in T-cells on TCR Vβ expression. Nature 358(6383), 255–259 (1992).
   PubMedGoogle Scholar
• Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N. Engl. J. Med. 328(23), 1670–1674 (1993).
   PubMed Web of Science ®Google Scholar
• Colebunders R, Blot K, Mertens V, Dockx P. Psoriasis regression in terminal AIDS. Lancet 339(8801), 1110 (1992).
   PubMed Web of Science ®Google Scholar
• Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Karkkainen P. Alcohol intake: a risk factor for psoriasis in young and middle aged men? Br. Med. J. 300(6727), 780–783 (1990).
   PubMed Web of Science ®Google Scholar
• Naldi L, Parazzini F, Brevi A et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br. J. Dermatol. 127(3), 212–217 (1992).
   PubMed Web of Science ®Google Scholar
• Mills CM, Srivastava ED, Harvey IM et al. Smoking habits in psoriasis: a case control study. Br. J. Dermatol. 127(1), 18–21 (1992).
   PubMed Web of Science ®Google Scholar
• Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br. J. Dermatol. 130(4), 473–477 (1994).
   PubMed Web of Science ®Google Scholar
• Naldi L. Cigarette smoking and psoriasis. Clin. Dermatol. 16(5), 571–574 (1998).
   PubMed Web of Science ®Google Scholar
• Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J. Invest. Dermatol. 125(1), 61–67 (2005).
   PubMed Web of Science ®Google Scholar
• O’Doherty CJ, MacIntyre C. Palmoplantar pustulosis and smoking. Br. Med. J. 291(6499), 861–864 (1985).
   PubMed Web of Science ®Google Scholar
• Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch. Dermatol. 135(12), 1479–1484 (1999).
   PubMedGoogle Scholar
• Huriez C, Desmons F, Benoit M, Martin P. Liver biopsy in eczema and other dermatoses. Br. J. Dermatol. 69(7–8), 237–244 (1957).
   PubMed Web of Science ®Google Scholar
• Behnam S, Behnam S, Koo Y. Alcohol as a risk factor for plaque-type psoriasis. Cutis 76, 181–185 (2005).
   PubMed Web of Science ®Google Scholar
• Chaput JC, Poynard T, Naveau S et al. Psoriasis, alcohol, and liver disease. Br. Med. J. 291(6487), 25 (1985).
   PubMed Web of Science ®Google Scholar
• Higgins EM, du Vivier AW. Cutaneous disease and alcohol misuse. Br. Med. Bull. 50(1), 85–98 (1994).
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang H, Te-Shao H, Yang S, Wang F. Frequent use of tobacco and alcohol in Chinese psoriasis patients. Int J. Dermatol. 41(10), 659–662 (2002).
   Google Scholar
• Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch. Dermatol. 135(12), 1490–1493 (1999).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Schork NJ, Gupta AK, Ellis CN. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J. Am. Acad. Dermatol. 28(5 Pt 1), 730–732 (1993).
   PubMed Web of Science ®Google Scholar
• Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM. Drugs in exacerbation of psoriasis. J. Am. Acad. Dermatol. 15(5 Pt 1), 1007–1022 (1986).
   PubMedGoogle Scholar
• Cox NH, Gordon PM, Dodd H. Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Br. J. Dermatol. 146(6), 1061–1063 (2002).
   PubMedGoogle Scholar
• Abel EA. Diagnosis of drug-induced psoriasis. Semin. Dermatol. 11(4), 269–274 (1992).
   PubMedGoogle Scholar
• Gaylor ML, Duvic M. Generalized pustular psoriasis following withdrawal of efalizumab. J. Drugs Dermatol. 3(1), 77–79 (2004).
   PubMedGoogle Scholar
• Cather JC, Cather JC, Menter A. Modulating T-cell responses for the treatment of psoriasis: a focus on efalizumab. Expert Opin. Biol. Ther. 3(2), 361–370 (2003).
   PubMed Web of Science ®Google Scholar
• Hannuksela-Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J. Invest. Dermatol. 114(3), 587–590 (2000).
   PubMed Web of Science ®Google Scholar
• Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J. Invest. Dermatol. 117(6), 1531–1537 (2001).
   PubMed Web of Science ®Google Scholar
• Frentz G, Olsen JH. Malignant tumours and psoriasis: a follow-up study. Br. J. Dermatol. 140(2), 237–242 (1999).
   PubMed Web of Science ®Google Scholar
• Margolis D, Bilker W, Hennessy S et al. The risk of malignancy associated with psoriasis. Arch. Dermatol. 137(6), 778–783 (2001).
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch. Dermatol. 139(11), 1425–1429 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Holford TR, Leaderer B et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 15(4), 419–428 (2004).
   PubMed Web of Science ®Google Scholar
• Bhate SM, Sharpe GR, Marks JM, Shuster S, Ross WM. Prevalence of skin and other cancers in patients with psoriasis. Clin. Exp. Dermatol. 18(5), 401–404 (1993).
   PubMed Web of Science ®Google Scholar
• Lindelof B, Eklund G, Liden S, Stern RS. The prevalence of malignant tumors in patients with psoriasis. J. Am. Acad. Dermatol. 22(6 Pt 1), 1056–1060 (1990).
   PubMed Web of Science ®Google Scholar
• Stern RS, Vakeva LH. Noncutaneous malignant tumors in the PUVA follow-up study: 1975–1996. J. Invest. Dermatol. 108(6), 897–900 (1997).
   PubMedGoogle Scholar
• Becker N, Deeg E, Rudiger T, Nieters A. Medical history and risk for lymphoma: results of a population-based case-control study in Germany. Eur. J. Cancer 41(1), 133–142 (2005).
   PubMed Web of Science ®Google Scholar
• Reed WB, Becker SW, Rohde R, Heiskell CL. Psoriasis and arthritis. Clinicopathologic study. Arch. Dermatol. 83, 541–548 (1961).
   PubMed Web of Science ®Google Scholar
• McDonald CJ, Calabresi P. Thromboembolic disorders associated with psoriasis. Arch. Dermatol. 107(6), 918 (1973).
   PubMedGoogle Scholar
• McDonald CJ, Calabresi P. Complication of psoriasis. JAMA 224(5), 629 (1973).
   PubMed Web of Science ®Google Scholar
• McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N. Engl. J. Med. 288(17), 912 (1973).
   PubMed Web of Science ®Google Scholar
• McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br. J. Dermatol. 99(5), 469–475 (1978).
   PubMed Web of Science ®Google Scholar
• Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin–angiotensin system in psoriatic patients. Acta Cardiol. 40(2), 199–205 (1985).
   PubMed Web of Science ®Google Scholar
• Henseler T, Christophers E. Disease concomitance in psoriasis. J. Am. Acad. Dermatol. 32(6), 982–986 (1995).
   PubMed Web of Science ®Google Scholar
• Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis in-patients but not in out-patients. Eur. J. Epidemiol. 19(3), 225–230 (2004).
   Google Scholar
• Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J. Invest. Dermatol. 91(3), 197–201 (1988).
   PubMed Web of Science ®Google Scholar
• Naldi L, Parazzini F, Peli L, Chatenoud L, Cainelli T. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br. J. Dermatol. 134(1), 101–106 (1996).
   PubMed Web of Science ®Google Scholar
• Vessey MP, Painter R, Powell J. Skin disorders in relation to oral contraception and other factors, including age, social class, smoking and body mass index. Findings in a large cohort study. Br. J. Dermatol. 143(4), 815–820 (2000).
   PubMed Web of Science ®Google Scholar
• Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am. J. Clin. Dermatol. 4(7), 441–447 (2003).
   PubMed Web of Science ®Google Scholar
• Gladman DD. Psoriatic arthritis. Rheum. Dis. Clin. North Am. 24(4), 829–844, (1998).
   PubMed Web of Science ®Google Scholar
• Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J. Rheumatol. 27(5), 1247–1250 (2000).
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Gladman DD, Mease PJ et al. Epidemiology of psoriatic arthritis in the population of the United States. J. Am. Acad. Dermatol. 53(4), 573 (2005).
   PubMed Web of Science ®Google Scholar
• Stern RS. The epidemiology of joint complaints in patients with psoriasis. J. Rheumatol. 12(2), 315–320 (1985).
   PubMed Web of Science ®Google Scholar
• Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q. J. Med. 62(238), 127–141 (1987).
   PubMedGoogle Scholar
• Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Co-operative Study Group on Seronegative Spondyloarthropathies. J. Rheumatol. 26(8), 1752–1756 (1999).
   PubMed Web of Science ®Google Scholar
• Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: results from a single out-patient clinic. I. Causes and risk of death. Arthritis Rheum. 40(10), 1868–1872 (1997).
   PubMed Web of Science ®Google Scholar
• Gladman DD, Cheung C, Ng CM, Wade JA. HLA-C locus alleles in patients with psoriatic arthritis (PsA). Hum. Immunol. 60(3), 259–261 (1999).
   PubMed Web of Science ®Google Scholar
• Eastmond CJ. Psoriatic arthritis. Genetics and HLA antigens. Baillieres Clin. Rheumatol. 8(2), 263–276 (1994).
   PubMed Web of Science ®Google Scholar
• Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129(3), 819–826 (2005).
   PubMed Web of Science ®Google Scholar
• Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn’s disease. J. Am. Acad. Dermatol. 48(6), 805–821 (2003).
   PubMed Web of Science ®Google Scholar
• Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn’s disease and their relatives. Am. J. Gastroenterol. 85(8), 962–963 (1990).
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411(6837), 599–603 (2001).
   PubMed Web of Science ®Google Scholar
• Yang H, Plevy SE, Taylor K et al. Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut 44(4), 519–526 (1999).
   PubMedGoogle Scholar
• Hugot JP, Laurent-Puig P, Gower-Rousseau C et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379(6568), 821–823 (1996).
   PubMed Web of Science ®Google Scholar
• Hampe J, Schreiber S, Shaw SH et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet. 64(3), 808–816 (1999).
   PubMed Web of Science ®Google Scholar
• Enlund F, Samuelsson L, Enerback C et al. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur. J. Hum. Genet. 7(7), 783–790 (1999).
   PubMed Web of Science ®Google Scholar
• Matthews D, Fry L, Powles A et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nature Genet. 14(2), 231–233 (1996).
   PubMed Web of Science ®Google Scholar
• Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123, 1102–1111 (2000).
   PubMed Web of Science ®Google Scholar
• Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R et al. Autoimmune diseases and multiple sclerosis. Rev. Neurol. 40(10), 594–597 (2005).
   PubMed Web of Science ®Google Scholar
• Midgard R, Gronning M, Riise T, Kvale G, Nyland H. Multiple sclerosis and chronic inflammatory diseases. A case-control study. Acta Neurol. Scand. 93(5), 322–328 (1996).
   PubMedGoogle Scholar
• Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br. J. Dermatol. 139(5), 846–850 (1998).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Suicidal ideation in psoriasis. Int. J. Dermatol. 32(3), 188–190 (1993).
   PubMed Web of Science ®Google Scholar
• Polenghi MM, Molinari E, Gala C et al. Experience with psoriasis in a psychosomatic dermatology clinic. Acta Derm. Venereol. Suppl. 186, 65–66 (1994).
   PubMedGoogle Scholar
• Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen. Hosp. Psychiatry. 9(3), 157–166 (1987).
   PubMed Web of Science ®Google Scholar
• Rubino IA, Sonnino A, Pezzarossa B, Ciani N, Bassi R. Personality disorders and psychiatric symptoms in psoriasis. Psychol. Rep. 77(2), 547–553 (1995).
   PubMed Web of Science ®Google Scholar
• Vidoni D, Campiutti E, D’Aronco R, De Vanna M, Aguglia E. Psoriasis and alexithymia. Acta Derm. Venereol. Suppl. 146, 91–92 (1989).
   PubMedGoogle Scholar
• Gupta MA, Gupta AK, Watteel GN. Early onset (< 40 years age) psoriasis is comorbid with greater psychopathology than late onset psoriasis: a study of 137 patients. Acta Derm. Venereol. 76(6), 464–466 (1996).
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, Weidmann A, Sweeney SK, Griffiths CE. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br. J. Dermatol. 151(6), 1227–1233 (2004).
   PubMed Web of Science ®Google Scholar
• Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J. Am. Acad. Dermatol. 20(1), 53–63 (1989).
   PubMed Web of Science ®Google Scholar
• Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J. Eur. Acad. Dermatol. Venereol. 14(4), 267–271 (2000).
   PubMed Web of Science ®Google Scholar
• Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J. Eur. Acad. Dermatol. Venereol. 16(4), 347–352 (2002).
   PubMed Web of Science ®Google Scholar
• Zachariae R, Zachariae C, Ibsen HH, Mortensen JT, Wulf HC. Psychological symptoms and quality of life of dermatology out-patients and hospitalized dermatology patients. Acta Derm. Venereol. 84(3), 205–212 (2004).
   PubMed Web of Science ®Google Scholar
• Fortune DG, Richards HL, Kirby B et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch. Dermatol. 139(6), 752–756 (2003).
   PubMedGoogle Scholar
• Payne RA, Rowland Payne CM, Marks R. Stress does not worsen psoriasis? – a controlled study of 32 patients. Clin. Exp. Dermatol. 10(3), 239–245 (1985).
   PubMedGoogle Scholar
• Picardi A, Pasquini P, Cattaruzza MS et al. Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J. Psychosom. Res. 55(3), 189–196 (2003).
   PubMed Web of Science ®Google Scholar